These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6532596)

  • 21. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats.
    Schiffrin EL; Thomé FS; Genest J
    Hypertension; 1983; 5(6 Pt 3):V16-21. PubMed ID: 6317555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the renin-angiotensin system in the initiation of renovascular hypertension.
    Barger AC
    Angiology; 1976 Jun; 27(6):341-6. PubMed ID: 802886
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of angiotensin in the salt-hypertension of rats.
    Meyer P; Worcel M
    Pflugers Arch; 1970; 317(4):327-35. PubMed ID: 4316341
    [No Abstract]   [Full Text] [Related]  

  • 24. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.
    Somers MJ; Mavromatis K; Galis ZS; Harrison DG
    Circulation; 2000 Apr; 101(14):1722-8. PubMed ID: 10758056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of the renin-angiotensin system in the development and maintenance of hypertension in the two-kidney one-clip hypertensive rat.
    Morton JJ; Wallace EC
    Clin Sci (Lond); 1983 Apr; 64(4):359-70. PubMed ID: 6186428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dual role of angiotensin and vasopressin as plasma hormones and neuropeptides in cardiovascular regulation.
    Ganten D; Unger T; Lang RE
    J Pharmacol; 1985; 16 Suppl 2():51-68. PubMed ID: 2867253
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac and renal hypertrophy is independent of tissue angiotensin converting enzyme and circulating angiotensin II in hypertensive rats.
    Mooser V; Katopothis A; Casley D; Johnston CI
    J Hypertens Suppl; 1991 Dec; 9(6):S114-5. PubMed ID: 1667995
    [No Abstract]   [Full Text] [Related]  

  • 28. Renin-aldosterone system suppression during water immersion in renovascular hypertension.
    Coruzzi P; Biggi A; Musiari L; Ravanetti C; Novarini A
    Clin Sci (Lond); 1985 May; 68(5):609-12. PubMed ID: 3884242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of altered dietary calcium intake in experimental hypertension: role of intracellular free magnesium.
    Resnick LM; Gupta RK; Sosa RE; Corbett ML; Sealey JE; Laragh JH
    J Hypertens Suppl; 1986 Dec; 4(5):S182-5. PubMed ID: 3553472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathophysiology of renovascular hypertension.
    Robertson JI; Morton JJ; Tillman DM; Lever AF
    J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salt sensitivity in Goldblatt hypertensive rats--role of extracellular fluid volume and renin-angiotensin system.
    Sato Y; Ando K; Ogata E; Fujita T
    Jpn Circ J; 1991 Feb; 55(2):165-73. PubMed ID: 2020087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implication of renin-angiotensin system on renal injury seen in Dahl salt-sensitive rats.
    Hirawa N; Uehara Y; Numabe A; Kawabata Y; Gomi T; Ikeda T; Ohnishi T; Ishii M; Omata M
    Am J Hypertens; 1997 May; 10(5 Pt 2):102S-106S. PubMed ID: 9160791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial pressure and renal function in two-kidney, one clip Goldblatt hypertensive rats maintained on a high-salt intake.
    Jackson CA; Navar LG
    J Hypertens; 1986 Apr; 4(2):215-21. PubMed ID: 3519764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The brain renin-angiotensin system and the development of DOC-salt hypertension.
    Basso N; Ruiz P; Kurnjek ML; Cannata MA; Taquini AC
    Clin Exp Hypertens A; 1985; 7(9):1259-68. PubMed ID: 3907896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypotensive effects of diltiazem in DOCA/saline hypertensive rats (author's transl)].
    Yamaguchi I; Ikezawa K; Murata S; Narita H; Ikeo T; Sato M
    Nihon Yakurigaku Zasshi; 1979 Mar; 75(2):191-9. PubMed ID: 395050
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological and endocrine features of a new experimental hypertension model: Heymann nephritis-DOCA-NaCl hypertension.
    Tikkanen I; Fyhrquist F
    Acta Med Scand Suppl; 1983; 677():130-3. PubMed ID: 6583994
    [No Abstract]   [Full Text] [Related]  

  • 38. Reversal of experimental renovascular hypertension.
    Edmunds ME; Russell GI; Bing RF
    J Hypertens; 1991 Apr; 9(4):289-301. PubMed ID: 1646257
    [No Abstract]   [Full Text] [Related]  

  • 39. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in convulsion threshold and changes in the action of certain sleep-inducing drugs in hypertensive rats (DOCA/NaCl and SHR).
    Czyzewska-Szafran H
    Acta Physiol Pol; 1980; 31(2):147-52. PubMed ID: 7395539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.